Microsatellite instability and alternative genetic pathway in intrahepatic cholangiocarcinoma

被引:46
作者
Momoi, H
Itoh, T
Nozaki, Y
Arima, Y
Okabe, H
Satoh, S
Toda, Y
Sakai, E
Nakagawara, K
Flemming, P
Yamamoto, M
Shimahara, Y
Yamaoka, Y
Fukumoto, M
机构
[1] Tohoku Univ, Dept Pathol, Inst Dev Aging & Canc, Aoba Ku, Sendai, Miyagi 9808575, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Surg Gastroenterol, Sakyo Ku, Kyoto 6068507, Japan
[3] Kyoto Univ, Ctr Anat Studies, Grad Sch med, Sakyo Ku, Kyoto 6068501, Japan
[4] Nihon Gene Res Labs Inc, Miyagino Ku, Sendai, Miyagi 9830034, Japan
[5] Hannover Med Sch, Inst Pathol, D-830625 Hannover, Germany
关键词
intrahepatic cholangiocarcinoma; carcinogenesis; K-ras; p53; mdm-2; microsatellite instability;
D O I
10.1016/S0168-8278(01)00106-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Intrahepatic cholangiocarcinoma (ICC) arises from intrahepatic bile duct epithelium and is the second most prevalent among primary liver cancers. The aim of this study was to clarify the mechanism of cholangiocarcinogenesis. Methods: We studied the incidence of microsatellite instability (NISI) involving eight highly polymorphic microsatellite markers and alternations of the K-ras, p53 and mdm-2 genes in human ICC tissues. Overexpression of mdm-2 oncoprotein was also immunohistochemically studied. Results: Of all 65 cases examined, K-ras gene mutation was found in three cases (4.6%) at codon 12.Analysis of p53 alterations was performed in 28 cases including 22 frozen samples and mutations were found in three cases (10.7%). Overexpression of mdm-2 protein was observed in 25 (41.7%) out of 60 cases analyzed. In 22 frozen samples, seven (31.8%) cases showed mdm-2 amplification and four (18.2%) cases revealed NISI-positive phenotype. Among the cases analyzed, all the tumors with mdm-2 amplification/overexpression harbored the wild-type p53 gene and all the microsatellite instability-positive cases were from mass-forming (NIF) + periductal-infiltrating (PI) subtype. Conclusions: These results suggest that mdm-2 plays a role, which might be partially through inhibiting p53 activity, in cholangiocarcinogenesis and that MSI is associated with a subset of MF +/- PI type tumors. (C) 2001 European Association for the Study of the Liver. Published by Elsevier Science BN. All rights reserved.
引用
收藏
页码:235 / 244
页数:10
相关论文
共 62 条
[1]   MOST HUMAN CARCINOMAS OF THE EXOCRINE PANCREAS CONTAIN MUTANT C-K-RAS GENES [J].
ALMOGUERA, C ;
SHIBATA, D ;
FORRESTER, K ;
MARTIN, J ;
ARNHEIM, N ;
PERUCHO, M .
CELL, 1988, 53 (04) :549-554
[2]  
[Anonymous], 1990, ANN SURG, V211, P277
[3]   MOLECULAR THEMES IN ONCOGENESIS [J].
BISHOP, JM .
CELL, 1991, 64 (02) :235-248
[4]  
Blattner C, 1999, MOL CELL BIOL, V19, P3704
[5]   PREVALENCE OF RAS GENE-MUTATIONS IN HUMAN COLORECTAL CANCERS [J].
BOS, JL ;
FEARON, ER ;
HAMILTON, SR ;
VERLAANDEVRIES, M ;
VANBOOM, JH ;
VANDEREB, AJ ;
VOGELSTEIN, B .
NATURE, 1987, 327 (6120) :293-297
[6]  
Dietmaier W, 1997, CANCER RES, V57, P4749
[7]  
Furubo S, 1999, HISTOPATHOLOGY, V35, P230
[8]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53
[9]   p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation [J].
Honda, K ;
Sbisà, E ;
Tullo, A ;
Papeo, PA ;
Saccone, C ;
Poole, S ;
Pignatelli, M ;
Mitry, RR ;
Ding, S ;
Isla, A ;
Davies, A ;
Habib, NA .
BRITISH JOURNAL OF CANCER, 1998, 77 (05) :776-782
[10]  
HRUBAN RH, 1993, AM J PATHOL, V143, P545